About this event
UPDATES
*IHI launched the first calls for proposals on 28 June*
The full topic texts and details of how to apply can be found on the following pages:
IHI call 1 | IHI call 2 | Call documents
*Matchmaking"
.
The kick-off and brokerage event was a great opportunity for potential applicants to learn more about the first IHI calls and meet potential partners.
Our one-day hybrid event took place on 14 June 2022 at Hotel Le Plaza Brussels and online. Creating project proposals and building strong, effective consortia was at the core of the day. We aimed to provide pertinent information; allow open and honest discussion as well as network building through face-to-face and virtual meetings.
In the first session, IHI presented the content of the calls and outlined the rules for participation. Topics covered were the research priorities of IHI, call conditions, and even specific opportunities for SMEs.
The second session was the moment for consortia building. In the room, there were available timeslots to make short elevator pitches on project proposals.
Whether you were in the room or in the virtual environment, you were be able to book one-on-one meetings through an online platform with representatives who have an interest in the same topics. This was a great opportunity to have face-to-face or virtual project idea discussions and to find partners to build a strong consortium.
There were coffee breaks and lots of time for questions and answers to get you rolling before the dedicated networking sessions.
Participation in the event was be free of charge! However, registration and profile activation was mandatory to attend the brokerage event. A networking lunch was provided for those in the room.
Presentations and videos
Welcome and introduction:
The state of play for the Innovative Health Initiative
Hugh Laverty, Head of Scientific Operations, IHI
Anna Chioti, Chair, Science and Innovation Panel, IHI
Click here for the recording and for the presentations 
Elisabetta Vaudano, responsible for topic 1, Call 1
Tek-Ang Lim, responsible for topic 2, Call 1
Oussama Karroum, responsible for topic 3, Call 1
Colm Carroll, responsible for topic 4, Call 1
Industry representatives
Matthias Müllenborn, Vice President, Novo Nordisk- contributor to topic 1, Call 2
Andrea Rappagliosi, Senior Vice President Market Access, Public Affairs & Communications, Edwards Lifesciences- contributor to topic 2, Call 2Click here for the recording and for the presentations
Call 1, topic 1 (Neurodegenerative)- Watch here or view the pitch list
Call 1, topic 2 (Image-guided diagnosis)- Watch here or view the pitch list
Call 1, topic 3 (Personalised oncology)- Watch here or view the pitch list
Call 1, topic 4 (Health data)- Watch here or view the pitch list
Call 2, all topics (Cardiovascular and early feasibility studies)-
Watch here or view the pitch list